Tetra Bio-Pharma (TSX: TBP) (OTC-Pink: TBPMF) (FRA: JAM1) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers.
Some statements in this page may contain forward-looking information. Please refer to Tetra Bio-Pharma's annual regulatory filing for the risks and uncertainties.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Ottawa, Ontario K1c1g5, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- tetrabiopharma.com
- Keywords
- Bio-Pharmaceutical, Drug Discovery, Clinical Programs, Clinical Trials, Regulatory, Cannabinoids, Endocannabinoid System.
- HQ
- Ottawa, Ontario
Tetra Bio-Pharma Questions
Tetra Bio-Pharma's website is tetrabiopharma.com
Tetra Bio-Pharma's LinkedIn profile is https://ca.linkedin.com/company/tetra-bio-pharma
Tetra Bio-Pharma has
5 employees.
View email and phone details for 5
employees at Tetra Bio-Pharma.
Tetra Bio-Pharma's industry is
Biotechnology Research
Tetra Bio-Pharma's top competitors are
Corealis Pharma Inc.,
Tetra Pharm Technologies,
Tetrapharma Royalty Corp.,
Capital Bioventures,
Liberannex Analytical Training & Research Centre,
Quantum Biopharma (Nasdaq: $qntm),
Virica Biotech,
Alk,
Kabs Laboratories Inc.,
Delon Laboratories.
Tetra Bio-Pharma's categories are Biotechnology Research
Tetra Bio-Pharma's founding year is 2015
